Molecules/LADIRATUZUMAB VEDOTIN

LADIRATUZUMAB VEDOTIN

Molecular Identity

Antibody drug conjugatePhase 2

Mechanism of action: Tubulin inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

LADIRATUZUMAB VEDOTINLADIRATUZUMAB VEDOTINALADIRATUZUMAB VEDOTINESGN-LIV1ASGNLIV1A

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to LADIRATUZUMAB VEDOTIN

Loading drug network...